These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22584792)

  • 1. Tumor markers in clinical practice: a review focusing on common solid cancers.
    Duffy MJ
    Med Princ Pract; 2013; 22(1):4-11. PubMed ID: 22584792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers in hemodialysis patients.
    Arican A; Ozdemir N; Sezer S; Erten Y; Güz G; Turan M; Inanoglu I; Haberal M
    Transplant Proc; 1999 Dec; 31(8):3367-8. PubMed ID: 10616509
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.
    Kirwan A; Utratna M; O'Dwyer ME; Joshi L; Kilcoyne M
    Biomed Res Int; 2015; 2015():490531. PubMed ID: 26509158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
    Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
    Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular methods for the diagnosis of cancer.
    Cairns P; Sidransky D
    Biochim Biophys Acta; 1999 Mar; 1423(2):C11-8. PubMed ID: 10214347
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation.
    Reiter MJ; Costello JE; Schwope RB; Lisanti CJ; Osswald MB
    J Comput Assist Tomogr; 2015; 39(6):825-34. PubMed ID: 26248153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring.
    Bidart JM; Thuillier F; Augereau C; Chalas J; Daver A; Jacob N; Labrousse F; Voitot H
    Clin Chem; 1999 Oct; 45(10):1695-707. PubMed ID: 10508114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
    Bekci TT; Senol T; Maden E
    J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
    Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of common seric tumor markers in patients with solid cancers.
    Gara S; Boussen H; Ghanem A; Guemira F
    Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Biomarkers in Screening for Cancer.
    Duffy MJ
    Adv Exp Med Biol; 2015; 867():27-39. PubMed ID: 26530358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tumor markers in patients with solid cancers: A critical review.
    Duffy MJ
    Eur J Intern Med; 2007 May; 18(3):175-84. PubMed ID: 17449388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour markers with clinically controlled cut-offs for suspected cancer.
    Bosch X; Molina R; Marrades R; Augé JM; Pellicé M; López-Soto A
    Eur J Clin Invest; 2021 Jul; 51(7):e13523. PubMed ID: 33594702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of serum tumor markers.
    Bates SE
    Ann Intern Med; 1991 Oct; 115(8):623-38. PubMed ID: 1716430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour markers.
    Pandha HS; Waxman J
    QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study.
    Turgutalp K; Ozhan O; Helvacı I; Ata A; Arican A; Boztepe B; Kıykım A
    Clin Chem Lab Med; 2013 Apr; 51(4):889-95. PubMed ID: 23314541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of serum tumor markers for the early diagnosis of neoplasm and in health exams for asymptomatic persons].
    Bernabé Caro R; Moreno Nogueira JA
    Rev Clin Esp; 2002 Apr; 202(4):212-4. PubMed ID: 12003731
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of tumor markers in gynecologic oncology.
    Olt G; Berchuck A; Bast RC
    Obstet Gynecol Surv; 1990 Sep; 45(9):570-7. PubMed ID: 1697940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.